Image de Google Jackets
Vue normale Vue MARC vue ISBD

A systematic review and meta-analysis of neuropathic pain associated with COVID-19

Par : Contributeur(s) : Type de matériel : TexteTexteLangue : français Détails de publication : 2024. Ressources en ligne : Abrégé : Background and objectiveNeuropathic pain is a complication of COVID-19 that has been occasionally reported and has received increased attention in the scientific literature. In this systematic review and meta-analysis, we aimed to provide information on the frequency of neuropathic pain associated with COVID-19.Databases and data treatmentWe systematically reviewed and analyzed literature regarding neuropathic pain associated with COVID-19. Literature searches were conducted in the PubMed, EMBASE, and Cochrane Library databases. We considered prospective and retrospective studies published up until September 2022 (limitations included English language, full-text publications, and studies including at least 10 patients). A random-effects meta-analysis was performed and heterogeneity and publication bias were assessed.ResultsWe identified 149 studies. We included 17 studies in the systematic review, and included 6 studies reporting the frequency of neuropathic pain in the acute/subacute phase of COVID-19 in the meta-analysis. The estimated frequency of neuropathic pain ranged between 0.4 and 25%. Forest plot analysis showed that the random effect overall frequency was 10% (95% CI: 5%–15%), with a high level of heterogeneity (Chi2 = 104; Tau2 = 0.004; df = 5; I2 = 95%; test for overall effect: Z = 3.584; p ConclusionsThe estimated frequency of neuropathic pain associated with COVID-19 should be interpreted with caution due to the high heterogeneity across studies and the lack of clear diagnostic criteria. Significance: Emerging evidence supports the development of neuropathic pain as a complication of COVID-19. However, longitudinal studies that enroll consecutive patients with COVID-19 and establish clear diagnostic criteria for neuropathic pain are needed to better assess the frequency of this condition.
Tags de cette bibliothèque : Pas de tags pour ce titre. Connectez-vous pour ajouter des tags.
Evaluations
    Classement moyen : 0.0 (0 votes)
Nous n'avons pas d'exemplaire de ce document

6

Background and objectiveNeuropathic pain is a complication of COVID-19 that has been occasionally reported and has received increased attention in the scientific literature. In this systematic review and meta-analysis, we aimed to provide information on the frequency of neuropathic pain associated with COVID-19.Databases and data treatmentWe systematically reviewed and analyzed literature regarding neuropathic pain associated with COVID-19. Literature searches were conducted in the PubMed, EMBASE, and Cochrane Library databases. We considered prospective and retrospective studies published up until September 2022 (limitations included English language, full-text publications, and studies including at least 10 patients). A random-effects meta-analysis was performed and heterogeneity and publication bias were assessed.ResultsWe identified 149 studies. We included 17 studies in the systematic review, and included 6 studies reporting the frequency of neuropathic pain in the acute/subacute phase of COVID-19 in the meta-analysis. The estimated frequency of neuropathic pain ranged between 0.4 and 25%. Forest plot analysis showed that the random effect overall frequency was 10% (95% CI: 5%–15%), with a high level of heterogeneity (Chi2 = 104; Tau2 = 0.004; df = 5; I2 = 95%; test for overall effect: Z = 3.584; p ConclusionsThe estimated frequency of neuropathic pain associated with COVID-19 should be interpreted with caution due to the high heterogeneity across studies and the lack of clear diagnostic criteria. Significance: Emerging evidence supports the development of neuropathic pain as a complication of COVID-19. However, longitudinal studies that enroll consecutive patients with COVID-19 and establish clear diagnostic criteria for neuropathic pain are needed to better assess the frequency of this condition.

PLUDOC

PLUDOC est la plateforme unique et centralisée de gestion des bibliothèques physiques et numériques de Guinée administré par le CEDUST. Elle est la plus grande base de données de ressources documentaires pour les Étudiants, Enseignants chercheurs et Chercheurs de Guinée.

Adresse

627 919 101/664 919 101

25 boulevard du commerce
Kaloum, Conakry, Guinée

Réseaux sociaux

Powered by Netsen Group @ 2025